Moreover, high expression of exogenous PSMD2 in breast cancer cells decreased the protein abundance of β-catenin (Fig. 5D) and increased the rate of β-catenin degradation (Fig. 5E). This evidence concerns the gene PSMD2 and breast carcinoma.